N-(4-Bromophenyl)-4-(6,7-dimethoxy-4-quinazolinyl)piperazine-1-carboxamide

  • June 21, 2020
  • By: echemhub

Atherosclerosis Therapy; Oncolytic Drugs; Treatment of Restenosis; Tyrosine Kinase Inhibitors